HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of axillary lymph node dissection (ALND) in patients with micrometastatic breast cancer.

AbstractBACKGROUND:
Sentinel lymph node (SLN) biopsy is the current prognostic tool for clinically node-negative breast cancer patients. If the SLN reveals macrometastasis, axillary lymph node dissection (ALND) is recommended. However, the use of ALND in patients with micrometastasis is debated. The objective of this study was to assess the utilization of ALND in the treatment of micrometastatic breast cancer.
METHODS:
An IRB approved, retrospective study of a pooled dataset of breast cancer patients with micrometastatic disease on SLN biopsy was performed. Patients diagnosed from 1999-2016 were identified via query of a single-institution National Comprehensive Cancer Network (NCCN) breast cancer database as well as a prospective tumor board.
RESULTS:
A total of 91 patients were diagnosed with micrometastatic nodal disease. The median age at diagnosis was 56 y (range: 31-85); median follow-up time was 47 mo (range: 0-203 mo). 42/91(46.2%) patients had ALND of which 37/42 (88.1%) were a second operation; 3/42(7.1%) patients had additional positive nodes found at ALND. 44/91 (48.4%) patients received radiation. 7/91 (7.7%) patients had a recurrence, 5/7 local, including one axillary (2.1%; patient declined ALND).
CONCLUSIONS:
Given that the risk of lymphedema after ALND ranges between 20%-53%, the morbidity of ALND may far exceed the likelihood of detecting further nodal involvement in women with micrometastatic disease: 7.1% in this series.
AuthorsMadison Collins, Cristina O'Donoghue, Weihong Sun, Jun-Min Zhou, Zhenjun Ma, Christine Laronga, Marie Catherine Lee
JournalThe Journal of surgical research (J Surg Res) Vol. 215 Pg. 55-59 (07 2017) ISSN: 1095-8673 [Electronic] United States
PMID28688661 (Publication Type: Evaluation Study, Journal Article)
CopyrightCopyright © 2017 Elsevier Inc. All rights reserved.
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Axilla
  • Breast Neoplasms (pathology, surgery)
  • Carcinoma, Ductal, Breast (pathology, surgery)
  • Carcinoma, Lobular (pathology, surgery)
  • Female
  • Florida
  • Follow-Up Studies
  • Humans
  • Lymph Node Excision (statistics & numerical data)
  • Lymphatic Metastasis
  • Middle Aged
  • Neoplasm Micrometastasis
  • Practice Patterns, Physicians' (statistics & numerical data)
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: